β¨ Education and Health Notices
6 JUNE
NEW ZEALAND GAZETTE
The said supplementary integration agreement was executed on 28 May 2002.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, corner of Grey and Bridge Streets, Hamilton.
Dated at Wellington this 28th day of May 2002.
KATHY PHILLIPS, Senior Manager, National Operations.
go3651
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
Hukarere School, Napier.
The said supplementary integration agreement was executed on 29 May 2002.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, 65 Waterloo Road, Lower Hutt.
Dated at Wellington this 29th day of May 2002.
KATHY PHILLIPS, Senior Manager, National Operations.
go3758
1559
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Acihexal 5%
Active Ingredient:
Aciclovir 5%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Hexal New Zealand Pty Limited
Manufacturer:
Soul Pattinson Manufacturing Pty Limited, Kingsgrove, New South Wales, Australia
Product:
Actos
Active Ingredient:
Pioglitazone hydrochloride 16.53mg equivalent to 15mg pioglitazone
Dosage Form:
Tablet
New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited
Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland
Product:
Actos
Active Ingredient:
Pioglitazone hydrochloride 33.06mg equivalent to 30mg pioglitazone
Dosage Form:
Tablet
New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited
Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland
Product:
Actos
Active Ingredient:
Pioglitazone hydrochloride 49.59mg equivalent to 45mg pioglitazone
Dosage Form:
Tablet
New Zealand Sponsor:
Eli Lilly and Company (NZ) Limited
Manufacturers:
Takeda Chemical Industries Limited, Yodogawa-ku, Osaka, Japan
Takeda Ireland Limited, Kilruddery, County Wicklow, Ireland
Product:
Elidel
Active Ingredient:
Pimecrolimus 10mg
Dosage Form:
Topical cream
New Zealand Sponsor:
Novartis New Zealand Limited
Manufacturer:
Novartis Pharma GmbH, Wehr, Germany
Dated this 29th day of May 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go3719
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 58
Gazette.govt.nz —
NZ Gazette 2002, No 58
β¨ LLM interpretation of page content
π
Supplementary Integration Agreement for Sacred Heart Girlsβ College
(continued from previous page)
π Education, Culture & Science28 May 2002
Private Schools, Integration, Hamilton
- KATHY PHILLIPS, Senior Manager, National Operations
π Supplementary Integration Agreement for Hukarere School
π Education, Culture & Science29 May 2002
Private Schools, Integration, Napier
- KATHY PHILLIPS, Senior Manager, National Operations
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare29 May 2002
Medicines, Distribution, Consent, New Zealand
- G. R. BOYD, Chief Advisor, Safety and Regulation